Biochemical and cytological studies of bleomycin actions on chromatin and chromosomes.
Interaction of bleomycin with nuclei isolated from a variety of mammalian cells resulted in the release of nucleosomes. When isolated mononucleosomes (core plus linker) were re-treated with bleomycin, no further degradation of DNA occurred. The results suggest that the bleomycin cleavage sites in chromatin are present only in the linker region and that there are probably only one or two cleavage sites per linker. The repeat lengths of nucleosomal DNA released by bleomycin from nuclei of different species are different; this variability is considered to reflect the length of the linker. Incorporation of BrdU into DNA did not alter the bleomycin action on nucleosomes. When mitotic cells were held at metaphase for a prolonged period, bleomycin caused a gradual disintegration of chromosomes, although the bleomycin cleavage sites in metaphase chromosomes were found to be the same as those in interphase nuclei.
D000818:Animals; D001761:Bleomycin / Q000494:pharmacology*; D002460:Cell Line; D002478:Cells, Cultured; D002645:Chickens / Q000097:blood; D002843:Chromatin / Q000378:metabolism*; D002875:Chromosomes / Q000187:drug effects*; D004247:DNA / Q000378:metabolism*; D004912:Erythrocytes / Q000648:ultrastructure; D006367:HeLa Cells; D006801:Humans; D007945:Leukemia, Lymphoid / Q000097:blood; D008214:Lymphocytes / Q000648:ultrastructure
D002843:Chromatin; D001761:Bleomycin; D004247:DNA